Literature DB >> 7159685

Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailability.

V H Lee, K W Morimoto, R E Stratford.   

Abstract

Being the major pathway by which topically applied ophthalmic drugs enter the eye, the cornea can control the amount of active drug ultimately absorbed by offering resistance to drug permeation and by metabolizing the drug during permeation. This research seeks to determine the esterase activity in the cornea and two of its component layers--epithelium and stroma-endothelium--so as to anticipate the extent to which drugs containing ester linkages will be metabolized during transport. This has been achieved by incubating corneal homogenates of albino and pigmented rabbits of various age groups with alpha-naphthyl acetate, the model substrate, and monitoring the fluorescence intensity due to alpha-naphthol as a function of time. The results indicate that: (1) esterase activity in the epithelium is approximately twice that in the stroma-endothelium; (2) esterase activity in the intact cornea is linearly related to those in the epithelium and the stroma-endothelium; and (3) the esterase activity in the cornea and its component layers varies with rabbit's age and strain. According to these results the bulk of esterase-mediated hydrolysis is expected to take place in the epithelium, so that the residence time of a drug in this tissue can have a significant impact on its ocular bioavailability.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159685     DOI: 10.1002/bdd.2510030402

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  5 in total

Review 1.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

2.  [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].

Authors:  L Meyer; J Bednarz; C C Müller-Goymann; S Reichl
Journal:  Ophthalmologe       Date:  2005-10       Impact factor: 1.059

3.  Improved corneal pilocarpine permeability with O,O'-(1,4-xylylene) bispilocarpic acid ester double prodrugs.

Authors:  P Suhonen; T Järvinen; P Rytkönen; P Peura; A Urtti
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

4.  Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.

Authors:  Suresh Katragadda; Sriram Gunda; Sudharshan Hariharan; Ashim K Mitra
Journal:  Int J Pharm       Date:  2008-03-22       Impact factor: 5.875

Review 5.  The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.

Authors:  Megan E Cavet; Heleen H DeCory
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-07       Impact factor: 2.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.